Owen Male

Owen Male currently serves as the Associate Director of Global Value & Access at BioNTech SE, where responsibilities include developing global strategies for pumitamig (BNT327) and the ADC portfolio. Prior to this role, Owen Male was with Charles River Associates from September 2018 to September 2025, progressing from Analyst to Associate Principal, leading global engagements to address strategic challenges in pricing, market access, and commercial strategy for biotechnology and pharmaceutical clients. Earlier experience includes a research assistant position at the University of Cambridge. Owen Male holds a degree from the University of Cambridge, earned between 2014 and 2017.